Pedersen E B, Brock A, Kornerup H J
Scand J Clin Lab Invest. 1976 Mar;36(2):137-40.
Serum amylase activity was measured in 29 nondialysed patients with severe renal failure, in 24 uraemic patients treated with chronic haemodialysis, and in 29 patients treated with renal allotransplantation. Simultaneous measurement of renal amylase activity clearance (CAm) and creatinine clearance (CCr) was performed in 25 patients with severe renal failure and in 19 transplanted patients. Serum amylase activity was elevated in all three groups. CAm was significantly correlated to CCr both in the group with severe renal failure and in the transplanted group. Unlike in the group of transplanted patients, the ratio CAm/CCr was significantly increased in patients with severe impaired renal function. It is concluded that the elevation of serum amylase activity in patients with impaired renal function is primarily due to decreased glomerular filtration rate. The value of CAm/CCr for diagnosing acute pancreatitis is doubtful in patients with severe renal disease.
对29例未透析的严重肾衰竭患者、24例接受慢性血液透析治疗的尿毒症患者以及29例接受同种异体肾移植治疗的患者测定了血清淀粉酶活性。对25例严重肾衰竭患者和19例移植患者同时进行了肾淀粉酶活性清除率(CAm)和肌酐清除率(CCr)的测定。所有三组患者的血清淀粉酶活性均升高。在严重肾衰竭组和移植组中,CAm与CCr均显著相关。与移植患者组不同,肾功能严重受损患者的CAm/CCr比值显著升高。得出的结论是,肾功能受损患者血清淀粉酶活性升高主要是由于肾小球滤过率降低。在严重肾病患者中,CAm/CCr用于诊断急性胰腺炎的价值存疑。